# ORSERDU

NDC: 72187-0101
Generic name: Elacestrant
Labeler / Manufacturer: Stemline Therapeutics, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20230127

FDA application: NDA217639

## Active ingredients

- ELACESTRANT: 86 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72187-0101"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72187-0101
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=aa66ae5c-2bd2-4444-8178-b55651e054ef